CAML-positivity, regardless of the cell count, also failed to demonstrate any significant association with the tumor stage (Table 3) (T1-2: 36.0%, 95%CI=22.9-50.8% versus T3-4: 30.7%, 95%CI=24.4-37.6%, p=0.4704), nor with lymph node invasion (N0: 39.6%, 95% KI=26.4-54.0% versus N+: 29.7%, 95% KI=23.4-36.6%, p=0.17). This evidence concerns the gene CAMLG and neoplasm.